Broker Recommendations Cerence Inc.

Stocks

CRNC

US1567271093

Software

Real-time Estimate Cboe BZX Other stock markets 03:02:49 2026-07-31 pm EDT			5-day change	1st Jan Change
8.510 ^USD	+2.65%		+1.78%	-19.60%

Jul. 07	SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout \| Stock Movers	MT
Jul. 02	Cerence Inc. Announces Resignation of Marcy Klevorn from Board and Committees, Effective July 1, 2026	CI

Broker Recommendations

Apr. 02	Cantor Fitzgerald Initiates Cerence at Overweight With $11 Price Target	MT
25-08-06	Cerence Q3 revenue beats expectations	RE
25-01-22	Needham Upgrades Cerence to Buy From Hold, $16 Price Target	MT
24-07-15	Evercore ISI Adjusts Cerence's Price Target to $5 From $8, Maintains In Line Rating	MT
24-07-12	Baird Adjusts Price Target on Cerence to $6 From $8, Maintains Neutral Rating	MT
24-05-10	Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating	MT
24-05-10	Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating	MT
24-05-10	Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50	MT
24-04-17	Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating	MT
24-02-07	Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating	MT
24-02-07	Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22	MT
23-11-29	Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating	MT
23-11-29	Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept	MT
23-11-28	Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating	MT
23-11-28	Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating	MT
23-11-28	Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating	MT
23-08-09	Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating	MT
23-05-11	Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating	MT
23-05-10	Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating	MT
23-02-10	Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating	MT
23-02-09	Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating	MT
23-02-09	Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating	MT
23-02-09	Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating	MT
23-02-09	Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating	MT
23-02-09	Craig-Hallum Upgrades Cerence to Buy From Hold, Price Target is $40	MT